Chugai Pharmaceutical Co., Ltd. (CHGCY)
OTCMKTS · Delayed Price · Currency is USD
22.19
+0.04 (0.16%)
Oct 30, 2025, 11:42 AM EDT
Chugai Pharmaceutical Employees
Chugai Pharmaceutical had 5,026 employees as of December 31, 2024. The number of employees decreased by 2,578 or -33.90% compared to the previous year.
Employees
5,026
Change (1Y)
-2,578
Growth (1Y)
-33.90%
Revenue / Employee
$1,631,789
Profits / Employee
$533,967
Market Cap
73.69B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5,026 | -2,578 | -33.90% |
| Dec 31, 2023 | 7,604 | -167 | -2.15% |
| Dec 31, 2022 | 7,771 | 107 | 1.40% |
| Dec 31, 2021 | 7,664 | 109 | 1.44% |
| Dec 31, 2020 | 7,555 | 161 | 2.18% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| American Oncology Network | 1,914 |
| Jushi Holdings | 1,234 |
| Glass House Brands | 374 |
| Silence Therapeutics | 116 |
| Elite Pharmaceuticals | 68 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| Nuo Therapeutics | 9 |
Chugai Pharmaceutical News
- 6 days ago - Chugai Pharmaceutical 9-month Net Income Rises - Nasdaq
- 10 days ago - Why Delcath Systems Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket - Benzinga
- 13 days ago - Rani Therapeutics surges on Chugai licensing deal, private placement - Seeking Alpha
- 13 days ago - Rani Teams Up With Chugai To Revolutionize Oral Drug Delivery For Rare Diseases - Benzinga
- 3 months ago - Chugai Pharmaceutical Co., Ltd. 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 3 months ago - Chugai Pharmaceutical Co., Ltd. (CHGCF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Chugai Pharmaceutical reports Q2 results - Seeking Alpha
- 5 months ago - Biotech behind Eli Lilly obesity pill aims for new standard of care - Financial Times